A bruised Eli Lilly buys rights to Centrexion's early-stage pain drug for $47.5M upfront - Endpoints News https://t.co/SApo8pUvIN
— IDRO (@IDROOhio) May 29, 2019
from Twitter https://twitter.com/IDROOhio
May 28, 2019 at 04:55PM
Tuesday, May 28, 2019
A bruised Eli Lilly buys rights to Centrexion's early-stage pain drug for $47.5M upfront - Endpoints News https://t.co/SApo8pUvIN
from Twitter https://twitter.com/IDROOhio
May 28, 2019 at 04:55PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment